Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

LOC642781 Activators

The term LOC642781 Activators would conceptually refer to a set of chemical compounds engineered to enhance the biological activity of a gene product from the locus named LOC642781. The LOC prefix typically indicates a particular location on the genome that has been identified and given a unique identifier. Activators, in a biochemical sense, are molecules that bind to a biological macromolecule and increase its activity. Hence, LOC642781 activators would be expected to interact with the protein encoded by the LOC642781 gene, resulting in an upregulation of its function. This could be achieved through direct interaction with the protein, leading to a change in its conformation that results in enhanced activity, or by affecting the transcriptional, translational, or post-translational processes that control the expression and function of the protein. The discovery and development of such activators would rely on a profound understanding of the protein's role within the cell, including its regulatory mechanisms, interaction partners, and the pathways it influences.

To identify and develop LOC642781 activators, researchers would embark on a comprehensive investigation to elucidate the structure and function of the LOC642781 gene product. This would involve a combination of bioinformatics analyses to predict protein domains and structures, as well as experimental approaches to confirm these predictions and understand the protein's role in cellular processes. Techniques such as gene expression analysis, protein interaction mapping, and functional assays would be employed to build a detailed profile of the protein's activity. Once a target site on the protein is identified, a library of chemical compounds would be synthesized or compiled, aiming to find molecules that can bind to the protein and enhance its activity. Screening assays would then be conducted to evaluate the ability of these compounds to activate the LOC642781 protein. Hits from the screening process would be chemically optimized through an iterative process, modifying their structure to improve specificity, binding affinity, and the ability to modulate the protein's activity. Through this process, a series of compounds would be generated, each designed to interact with the LOC642781 protein in a specific manner to increase its biological activity without affecting other cellular functions.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$28.00
$38.00
5
(0)

A non-selective beta-adrenergic agonist that could cause a compensatory increase in PDE4D to regulate cAMP levels.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

A PDE4 inhibitor that might cause a feedback increase in PDE4D expression to restore cAMP homeostasis.

PGE2

363-24-6sc-201225
sc-201225C
sc-201225A
sc-201225B
1 mg
5 mg
10 mg
50 mg
$57.00
$159.00
$275.00
$678.00
37
(1)

Can modulate cAMP levels, which may indirectly lead to changes in PDE4D expression to regulate intracellular cAMP.

Theophylline

58-55-9sc-202835
sc-202835A
sc-202835B
5 g
25 g
100 g
$20.00
$32.00
$85.00
6
(0)

A non-specific PDE inhibitor; chronic use might upregulate PDE4D expression as a compensatory response.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

A non-selective PDE inhibitor; could lead to increased PDE4D expression to regulate cAMP levels.

Caffeine

58-08-2sc-202514
sc-202514A
sc-202514B
sc-202514C
sc-202514D
50 g
100 g
250 g
1 kg
5 kg
$33.00
$67.00
$97.00
$192.00
$775.00
13
(1)

A non-specific PDE inhibitor which might upregulate PDE4D expression as part of a homeostatic response.

(−)-Epinephrine

51-43-4sc-205674
sc-205674A
sc-205674B
sc-205674C
sc-205674D
1 g
5 g
10 g
100 g
1 kg
$41.00
$104.00
$201.00
$1774.00
$16500.00
(1)

As a hormone and neurotransmitter, it can affect cAMP levels and possibly induce PDE4D expression.